Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

More EU countries to adopt the euro:

This article was originally published in Clinica

Executive Summary

Four out of the ten new EU member states plan to adopt the euro currency by 2007 and the remaining six by 2010. Estonia, Cyprus, Lithuania and Slovenia are the frontrunners, according to the European Commission's first report on the state of practical preparation for the euro in the new member states. There are still questions over how the new currency will be introduced in these countries - either all at once, or with a transition period. The Commission report notes that the current euro area countries (except Greece) had a transitional period of three years, but the lessons drawn since show that this is neither necessary nor advisable for the new countries. A short or immediate transition strengthens the case for starting preparations at an early stage in order to allow a full changeover on "E-day", it says.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT060206

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel